Amgen (AMGN) May weekly 272 straddle priced into quarter results

Go back to Amgen (AMGN) May weekly 272 straddle priced into quarter results

Amgen (AMGN) PT Raised to $307 at UBS

May 3, 2024 7:06 AM EDT

UBS analyst Colin Bristow raised the price target on Amgen (NASDAQ: AMGN) to $307.00 (from $284.00) while maintaining a Neutral rating.

The analyst comments "The much anticipated MariTide interim completed (earlier than we expected) with mgmt providing positive qualitative commentary, as we had expected. At face... More